Evaluating the Role of Stress Hyperglycemia Ratio in Risk Assessment and Treatment Enhancement for Patients Undergoing Invasive Mechanical Ventilation: Insights from a Secondary Analysis of the MIMIC-IV Database - Scorecard - MDSpire

Evaluating the Role of Stress Hyperglycemia Ratio in Risk Assessment and Treatment Enhancement for Patients Undergoing Invasive Mechanical Ventilation: Insights from a Secondary Analysis of the MIMIC-IV Database

  • By

  • Kai Wang

  • Fangqin Lou

  • Shiqi Tian

  • Guibo Feng

  • January 24, 2026

  • 0 min

Share

Clinical Scorecard: Evaluating the Role of Stress Hyperglycemia Ratio in Risk Assessment and Treatment Enhancement for Patients Undergoing Invasive Mechanical Ventilation: Insights from a Secondary Analysis of the MIMIC-IV Database

At a Glance

CategoryDetail
ConditionInvasive Mechanical Ventilation (IMV)
Key MechanismsStress hyperglycemia ratio (SHR) as a metric for assessing metabolic response and mortality risk.
Target PopulationCritically ill patients undergoing IMV.
Care SettingIntensive Care Unit (ICU)

Key Highlights

  • SHR correlates with increased mortality risk in various critical conditions.
  • IMV patients face a short-term mortality risk of 40% to 50%.
  • Complications from IMV include ventilator-associated pneumonia (VAP) and acute kidney injury (AKI).
  • SHR provides a clearer depiction of acute hyperglycemia considering chronic glycemic status.
  • The study utilized the MIMIC-IV database for secondary analysis.

Guideline-Based Recommendations

Diagnosis

  • Utilize SHR for assessing metabolic state in critically ill patients.

Management

  • Implement proactive risk assessment and monitoring strategies in IMV patients.

Monitoring & Follow-up

  • Regularly evaluate SHR alongside other clinical parameters to inform treatment decisions.

Risks

  • Be aware of the high mortality risk and complications associated with prolonged IMV.

Patient & Prescribing Data

Critically ill patients requiring invasive mechanical ventilation.

SHR may enhance treatment strategies and risk assessment in this population.

Clinical Best Practices

  • Incorporate SHR in the evaluation of critically ill patients to guide clinical decisions.
  • Monitor for complications such as AKI and VAP in patients on IMV.

References

Original Source(s)

Related Content